Skip to main content
    S

    Sotera Health Co (SHC)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $16.25
    -0.36 (-2.17%)

    Market Cap: $4.74B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Sotera Health Co (SHC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Sotera Health (SHC) to earn $0.98 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.24B. Of 10 analysts, 8 rate the stock Buy or Strong Buy, 1 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 10 ratings average 2.10, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.

    RatingAnalystsShare
    Strong Buy330.0%
    Buy550.0%
    Hold110.0%
    Sell00.0%
    Strong Sell110.0%
    Consensus
    Buy
    Total analysts
    10

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 9.2% and revenue estimates rise 5.6%.

    Fiscal year ending Dec 31, 2026
    $0.98
    EPS consensus, revenue $1.24B
    Fiscal year ending Dec 31, 2027
    $1.07
    EPS consensus, revenue $1.31B
    Next report
    Feb 22, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.98$0.98 to $1.0010$1.24B$1.24B to $1.25B9
    Dec 31, 2027$1.07$1.03 to $1.1310$1.31B$1.31B to $1.32B9

    Quarterly Estimates

    The EPS consensus falls from $0.26 for the quarter ending Dec 31, 2026 to $0.20 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.26$0.25 to $0.2811$321.41M$308.70M to $341.04M11
    Mar 31, 2027$0.20$0.18 to $0.228$294.32M$292.67M to $296.33M6

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 3 upward and 6 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202621
    Fiscal year ending Dec 31, 202715

    EPS Trend

    The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$0.98$0.98$0.98$0.98$0.98-0.2%
    Fiscal year ending Dec 31, 2027$1.07$1.08$1.08$1.07$1.07-0.9%
    Quarter ending Mar 31, 2027$0.20$0.20$0.20$0.20$0.20+1.1%

    Frequently Asked Questions About SHC

    What is the SHC stock forecast?

    Consensus analyst estimates put Sotera Health's EPS at $0.98 for the fiscal year ending Dec 31, 2026, on revenue of $1.24B. The consensus rating from 10 analysts is Buy.

    How do analysts rate SHC stock?

    Of 10 analysts covering Sotera Health, 3 rate it Strong Buy, 5 Buy, 1 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SHC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.98, with estimates from $0.98 to $1.00 from 10 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.07, with estimates from $1.03 to $1.13 from 10 analysts.

    What revenue do analysts expect from Sotera Health next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.24B, with estimates from $1.24B to $1.25B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.31B, with estimates from $1.31B to $1.32B.

    How many analysts cover SHC?

    10 analysts rate Sotera Health stock, and 10 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.